Ayurcann Holdings Corp. (AYUR.CN)
| Previous Close | 0.0250 |
| Open | 0.0300 |
| Bid | 0.0300 x N/A |
| Ask | 0.0450 x N/A |
| Day's Range | 0.0300 - 0.0400 |
| 52 Week Range | 0.0100 - 0.0800 |
| Volume | |
| Avg. Volume | 56,229 |
| Market Cap | 4.867M |
| Beta (5Y Monthly) | 2.29 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings Date | May 27, 2024 - May 31, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireAYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE
Toronto, Ontario, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and manufacturing of various derivative cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three and six months ended December 31, 2023, the highlights of which are included in this news release. All fi
- GlobeNewswire
Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs
Pickering, Ontario, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is please to announce the following corporate updates. Corporate Update With the growth of the cannabis market and new pr
- GlobeNewswire
AYURCANN ANNOUNCES AGSM RESULTS
Toronto, Ontario, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company, specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is pleased to provide the following corporate updates. Annual General and Special Meeting The Company is pleased to announ
